Sibel Suzen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sibel Suzen has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Luciano Saso
Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, Rome, Italy
8 shared publications - Hande Gurer-Orhan
Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ege University, 35040 Izmir, Türkiye
5 shared publications Tulay Coban
Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Ankara University, 06100 Tandogan, Ankara, Turkey
4 shared publicationsErdem Buyukbingol
3 shared publications- Fernanda Borges
CIQUP-IMS - Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, R. Campo Alegre s/n, 4169-007 Porto, Portugal
3 shared publications Hanif Shirinzadeh
Department of Pharmaceutical Chemistry, Ankara Univetsity, Tandogan, Turkey
2 shared publications
Latest Publications
- Open Access
- 31 May 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (6) , 692
A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
Clinical and preclinical research indicates that neurodegenerative diseases are characterized by excess levels of oxidative stress (OS) biomarkers and by lower levels of antioxidant protection in the brain and peripheral tissues. Dysregulations in the oxidant/antioxidant balance are known to be a major factor in the pathogenesis of neurodegenerative diseases and involve mitochondrial dysfunction, protein misfolding, and neuroinflammation, all events that lead to the proteostatic collapse of neuronal cells and their loss. Nuclear factor-E2-related factor 2 (Nrf2) is a short-lived protein that works as a transcription factor and is related to the expression of many cytoprotective genes involved in xenobiotic metabolism and antioxidant responses. A major emerging function of Nrf2 from studies over the past decade is its role in resistance to OS. Nrf2 is a key regulator of OS defense and research supports a protective and defending role of Nrf2 against neurodegenerative conditions. This review describes the influence of Nrf2 on OS and in what way Nrf2 regulates antioxidant defense for neurodegenerative conditions. Furthermore, we evaluate recent research and evidence for a beneficial and potential role of specific Nrf2 activator compounds as therapeutic agents.
- 31 May 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (6) , 692
Open AccessA Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
Clinical and preclinical research indicates that neurodegenerative diseases are characterized by excess levels of oxidative stress (OS) biomarkers and by lower levels of antioxidant protection in the brain and peripheral tissues. Dysregulations in the oxidant/antioxidant balance are known to be a major factor in the pathogenesis of neurodegenerative diseases and involve mitochondrial dysfunction, protein misfolding, and neuroinflammation, all events that lead to the proteostatic collapse of neuronal cells and their loss. Nuclear factor-E2-related factor 2 (Nrf2) is a short-lived protein that works as a transcription factor and is related to the expression of many cytoprotective genes involved in xenobiotic metabolism and antioxidant responses. A major emerging function of Nrf2 from studies over the past decade is its role in resistance to OS. Nrf2 is a key regulator of OS defense and research supports a protective and defending role of Nrf2 against neurodegenerative conditions. This review describes the influence of Nrf2 on OS and in what way Nrf2 regulates antioxidant defense for neurodegenerative conditions. Furthermore, we evaluate recent research and evidence for a beneficial and potential role of specific Nrf2 activator compounds as therapeutic agents.
- Open Access
- 24 April 2020
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 27 (13) , 2038-2039
Chemistry and Pharmacology of Modulators of Oxidative Stress
- 24 April 2020
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 27 (13) , 2038-2039
Open AccessChemistry and Pharmacology of Modulators of Oxidative Stress
- 3 November 2018
- Published by Springer Nature
- p. 217-235
Melatonin and Its Antiaging Activity: New Approaches and Strategies for Age-Related Disorders
- 3 November 2018
- Published by Springer Nature
- p. 217-235
Melatonin and Its Antiaging Activity: New Approaches and Strategies for Age-Related Disorders
- 20 April 2018
- Published by Bentham Science Publishers Ltd.
- p. 131-172
In Vitro Methods for the Evaluation of Oxidative Stress
- 20 April 2018
- Published by Bentham Science Publishers Ltd.
- p. 131-172
In Vitro Methods for the Evaluation of Oxidative Stress
- Open Access
Detection of Reactive Oxygen and Nitrogen Species by Electron Paramagnetic Resonance (EPR) Technique
During the last decade there has been growing interest in physical-chemical oxidation processes and the behavior of free radicals in living systems. Radicals are known as intermediate species in a variety of biochemical reactions. Numerous techniques, assays and biomarkers have been used to measure reactive oxygen and nitrogen species (ROS and RNS), and to examine oxidative stress. However, many of these assays are not entirely satisfactory or are used inappropriately. The purpose of this chapter is to review current EPR (Electron Paramagnetic Resonance) spectroscopy methods for measuring ROS, RNS, and their secondary products, and to discuss the strengths and limitations of specific methodological approaches.
Open AccessDetection of Reactive Oxygen and Nitrogen Species by Electron Paramagnetic Resonance (EPR) Technique
During the last decade there has been growing interest in physical-chemical oxidation processes and the behavior of free radicals in living systems. Radicals are known as intermediate species in a variety of biochemical reactions. Numerous techniques, assays and biomarkers have been used to measure reactive oxygen and nitrogen species (ROS and RNS), and to examine oxidative stress. However, many of these assays are not entirely satisfactory or are used inappropriately. The purpose of this chapter is to review current EPR (Electron Paramagnetic Resonance) spectroscopy methods for measuring ROS, RNS, and their secondary products, and to discuss the strengths and limitations of specific methodological approaches.
- 1 April 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (8) , 1658-1664
Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage
- 1 April 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (8) , 1658-1664
Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage
- 26 December 2014
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 22 (4) , 490-499
Melatonin, its Metabolites and its Synthetic Analogs as Multi-Faceted Compounds: Antioxidant, Prooxidant and Inhibitor of Bioactivation Reactions
It is known that melatonin (MLT) and some of its metabolites act as antioxidants by scavenging free radicals as well as increasing the activity of antioxidant enzymes in the body. MLT is suggested to exert beneficial effects via various mechanisms in the treatment of many diseases, such as cancer, neurodegenerative diseases, epilepsy, diabetes mellitus and obesity. People working in nightshift exhibit decreased MLT levels that are suggested to be related with increased risk of hormone-related diseases. Similarly blind people were found to have increased MLT levels protecting against many diseases. This review briefly summarizes the published reports supporting these beneficial effects of MLT. Furthermore the present review involves recent developments related to the antioxidant effect of remarkable and multi-faceted molecule MLT as well as its metabolites and its synthesized analogues. The role of MLT as an inhibitor of bioactivation reactions is also discussed.
- 26 December 2014
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 22 (4) , 490-499
Melatonin, its Metabolites and its Synthetic Analogs as Multi-Faceted Compounds: Antioxidant, Prooxidant and Inhibitor of Bioactivation Reactions
It is known that melatonin (MLT) and some of its metabolites act as antioxidants by scavenging free radicals as well as increasing the activity of antioxidant enzymes in the body. MLT is suggested to exert beneficial effects via various mechanisms in the treatment of many diseases, such as cancer, neurodegenerative diseases, epilepsy, diabetes mellitus and obesity. People working in nightshift exhibit decreased MLT levels that are suggested to be related with increased risk of hormone-related diseases. Similarly blind people were found to have increased MLT levels protecting against many diseases. This review briefly summarizes the published reports supporting these beneficial effects of MLT. Furthermore the present review involves recent developments related to the antioxidant effect of remarkable and multi-faceted molecule MLT as well as its metabolites and its synthesized analogues. The role of MLT as an inhibitor of bioactivation reactions is also discussed.